These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34044079)

  • 1. A systematic review on Zhilong Huoxue Tongyu capsule in treating cardiovascular and cerebrovascular diseases: Pharmacological actions, molecular mechanisms and clinical outcomes.
    Liang P; Mao L; Ma Y; Ren W; Yang S
    J Ethnopharmacol; 2021 Sep; 277():114234. PubMed ID: 34044079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Zhilong Huoxue Tongyu capsule in the treatment of acute cerebral infarction: A systematic review and meta-analysis of randomized controlled trials.
    Liu M; Pu Y; Gu J; He Q; Liu Y; Zeng Y; Li J; Long X; Yang S; Wu Q; Zhou H
    Phytomedicine; 2021 Jun; 86():153566. PubMed ID: 33940333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zhilong Huoxue Tongyu Capsule attenuates hemorrhagic transformation through the let-7f/TLR4 signaling pathway.
    Geng L; Zheng LZ; Kang YF; Pan CL; Wang T; Xie C; Liang B; Liao HL
    J Ethnopharmacol; 2023 Aug; 312():116521. PubMed ID: 37080368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zhilong Huoxue Tongyu Capsule regulates the macrophage polarization and inflammatory response via the let-7i/TLR9/MyD88 signaling pathway.
    Kang YF; Bai X; Wang KY; Wang T; Pan CL; Xie C; Liang B; Liao HL
    J Ethnopharmacol; 2024 Aug; 330():118208. PubMed ID: 38636581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zhilong Huoxue Tongyu capsule alleviates myocardial fibrosis by improving endothelial cell dysfunction.
    Bi T; Zhou Y; Mao L; Liang P; Liu J; Yang L; Ren G; Mazhar M; Shen H; Liu P; Spáčil R; Guo Q; Luo G; Yang S; Ren W
    J Tradit Complement Med; 2024 Jan; 14(1):40-54. PubMed ID: 38223805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zhilong Huoxue Tongyu capsule improves myocardial ischemia/reperfusion injury via the PI3K/AKT/Nrf2 axis.
    Zhao X; Yang F; Wu H; Fan Z; Wei G; Zou Y; Xue J; Liu M; Chen G
    PLoS One; 2024; 19(4):e0302650. PubMed ID: 38687744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Ferroptosis Mechanism of Zhilong Huoxue Tongyu Capsule for the Treatment of Intracerebral Hemorrhage Based on Network Pharmacology and
    Wang L; Ren W; Wang L; Mao L; Mazhar M; Zhou C; Xu H; Yang S
    Evid Based Complement Alternat Med; 2022; 2022():5033135. PubMed ID: 36199551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zhilong Huoxue Tongyu capsule inhibits rabbit model of hyperlipidemia and atherosclerosis through NF-κB/NLRP3 signaling pathway.
    Liu M; Wang R; Chen M; Hu Z; Han M; Mazhar M; Xue J; Zou Y; Wu Q; Yang S
    Heliyon; 2023 Nov; 9(11):e20026. PubMed ID: 38027979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Network Mechanism of Zhilong Huoxue Tongyu Capsule in Treating Cerebral Ischemia-Reperfusion.
    Li N; Sun J; Chen JL; Bai X; Wang TH
    Front Pharmacol; 2022; 13():912392. PubMed ID: 35873563
    [No Abstract]   [Full Text] [Related]  

  • 10. Zhilong Huoxue Tongyu Capsule Alleviated the Pyroptosis of Vascular Endothelial Cells Induced by ox-LDL through miR-30b-5p/NLRP3.
    Liu M; Luo G; Liu T; Yang T; Wang R; Ren W; Liu P; Lai X; Zhou H; Yang S
    Evid Based Complement Alternat Med; 2022; 2022():3981350. PubMed ID: 35126599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in chemistry and bioactivity of Sargentodoxa cuneata.
    Zhang W; Sun C; Zhou S; Zhao W; Wang L; Sheng L; Yi J; Liu T; Yan J; Ma X; Fang B
    J Ethnopharmacol; 2021 Apr; 270():113840. PubMed ID: 33460761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological mechanism and clinical study of Qiming granules in treating diabetic retinopathy based on network pharmacology and literature review.
    Huang Y; Wang J; Wang Y; Kuang W; Xie M; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115861. PubMed ID: 36332761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zhilong Huoxue Tongyu Capsule Ameliorates Platelet Aggregation and Thrombus Induced by Aspirin in Rats by Regulating Lipid Metabolism and MicroRNA Pathway.
    Qiuyue L; Gulin D; Hong X; Jiazhen Y; Rukui Y; Xinwu H; Guochun L
    Comb Chem High Throughput Screen; 2024; 27(6):854-862. PubMed ID: 37438906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danhong injection in cardiovascular and cerebrovascular diseases: Pharmacological actions, molecular mechanisms, and therapeutic potential.
    Feng X; Li Y; Wang Y; Li L; Little PJ; Xu SW; Liu S
    Pharmacol Res; 2019 Jan; 139():62-75. PubMed ID: 30408571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on the mechanisms of guiqi huoxue capsule for treating cervical spondylosis based on network pharmacology and molecular docking.
    Liu Y; Zhang J; Liu X; Zhou W; Stalin A; Fu C; Wu J; Cheng G; Guo S; Jia S; Li B; Wang H; Li J; Lu S
    Medicine (Baltimore); 2021 Sep; 100(37):e26643. PubMed ID: 34664825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on influencing factors of valid patents of compound traditional Chinese medicines for cardiovascular and cerebrovascular diseases on base of regression analysis].
    Yan XJ; Xiao SY
    Zhongguo Zhong Yao Za Zhi; 2013 Mar; 38(6):919-23. PubMed ID: 23717980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review on the chemical profiles, quality control, pharmacokinetic and pharmacological properties of Fufang Xueshuantong Capsule.
    Zeng X; Zheng Y; Luo J; Liu H; Su W
    J Ethnopharmacol; 2021 Mar; 267():113472. PubMed ID: 33068651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regularity of traditional Chinese medicine prescriptions for same treatment for cardiovascular and cerebrovascular diseases].
    Gao JM; Lyu M; Xie WW; Liu XY; Zhao BC; Zhu Y
    Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(1):193-198. PubMed ID: 30868832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications.
    Chen Q; Zou J; Shi Y; Zhang X; Guo D; Luan F; Sun J
    Phytomedicine; 2024 Sep; 132():155674. PubMed ID: 38901283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospect of research on anti-atherosclerosis effect of main components of traditional Chinese medicine Yiqi Huoxue Huatan recipe through gut microbiota: A review.
    Huang H; Zhao H; Wenqing L; Xu F; Wang X; Yao Y; Huang Y
    Medicine (Baltimore); 2024 Feb; 103(5):e37104. PubMed ID: 38306512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.